Please login to the form below

Not currently logged in

drug-device combinations

This page shows the latest drug-device combinations news and features for those working in and with pharma, biotech and healthcare.

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Mitsubishi buys Israel's NeuroDerm for $1.1bn

The deal will see it focus on a series of drug-device combinations for Parkinson’s disease, headed by phase III candidate ND0612. ... The $39-per-share deal will see NeuroDerm merged with Mitsubishi's Israeli unit to become a wholly-owned subsidiary

Latest news

  • Medtronic and Samsung partner on diabetes device Medtronic and Samsung partner on diabetes device

    In addition to this, Sanofi also worked with Medtronic to develop drug device combinations for patients with type 2 diabetes. .

  • Sanofi and Medtronic to develop drug-device combos in diabetes Sanofi and Medtronic to develop drug-device combos in diabetes

    Sanofi has entered a partnership with US-based medical device firm Medtronic to develop drug-device combinations for people with type 2 diabetes.

  • Drug-device convergence Drug-device convergence

    Drug-device combinations have been around for more than 50 years, with transdermal patches delivering drugs, stents coated with anticoagulants, inhaled medicines and drugs bundled alongside diagnostics all coming under the ... All told, the global market

  • MHRA launches virtual 'innovation office' MHRA launches virtual 'innovation office'

    The UK regulator wants to help firms working on things like novel drug-device combinations or nanomedicines to navigate its regulatory processes through early dialogue. ... Areas of technology that are a current focus for the regulator include novel

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Spectrum Regulatory Solutions

    We serve the following industry segments: pharmaceutical, biologics, medical devices, drug device combinations, nutraceuticals, functional foods and veterinary.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....